Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

1,012 public trials 175 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Recruiting

Study of GV20-0251 in Participants With Solid Tumor Malignancies

NCT07070518

Conditions
Adenocarcinoma, Adult Refractory Cancer, Bronchial Neoplasms, +44 more
Locations
  • Beijing Cancer Hospital Beijing, Beijing Municipality, China
  • Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China
  • Shanghai Pulmonary Hospital Shanghai, Shanghai Municipality, China
View Trial Details
Recruiting

DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition

NCT05770102

Conditions
Cancer, Colonic Diseases, Colorectal Neoplasms, +37 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Bristol Royal Hospital for Children Bristol, United Kingdom
View all 27 locations
View Trial Details
Recruiting

DETERMINE Trial Treatment Arm 05: Vemurafenib in Combination With Cobimetinib in Adult Patients With BRAF Positive Cancers.

NCT05768178

Conditions
Adenocarcinoma, Adenocarcinoma, Papillary, Adnexal Diseases, +74 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Bristol Haematology and Oncology Centre Bristol, United Kingdom
  • Addenbrooke's Hospital Cambridge, United Kingdom
View all 16 locations
View Trial Details
Recruiting

DETERMINE Trial Treatment Arm 03: Entrectinib in Adult, Paediatric and Teenage/Young Adult Patients With ROS1 Gene Fusion-Positive Cancers.

NCT05770544

Conditions
Brain Diseases, Brain Neoplasms, Cancer, +30 more
Locations
  • Belfast City Hospital Belfast, United Kingdom
  • University Hospital Birmingham Birmingham, United Kingdom
  • Birmingham Children's Hospital Birmingham, United Kingdom
  • Bristol Royal Hospital for Children Bristol, United Kingdom
View all 27 locations
View Trial Details
Recruiting

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

NCT03452774

Conditions
Adenocarcinoma, Adnexal Diseases, Astrocytoma, +144 more
Locations
  • Massive Bio SYNERGY-AI site Birmingham, Alabama, United States
  • Massive Bio SYNERGY-AI site Mobile, Alabama, United States
  • Massive Bio SYNERGY-AI site Scottsdale, Arizona, United States
  • Massive Bio SYNERGY-AI site Little Rock, Arkansas, United States
View all 68 locations
View Trial Details
Recruiting

A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors

NCT04370587

Conditions
Carcinoma, Carcinoma, Squamous Cell, HNSCC, +21 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States
View Trial Details

Related conditions